YAP1 and cancer: Recent advances in medicinal chemistry lead to potent Hippo pathway inhibitors and have demonstrated promising results in inhibiting YAP/TEAD transcriptional activity, altering in vitro VM, and reducing cancer cell migration [25, 26, 27, 28].